Funding Body: World Bank
Type of Funding: Private
Main Research: Prashant Yadav
Other Researchers: Simón Conesa
Term: 24/02/2009-15/04/2009
Project Description
A deeper and structured understanding of the supply chain for medicines in low and middle income countries represents an important gap in our current knowledge although such information is key to the development of remedial policy interventions that can improve overall access to medicines. This study focuses in Jordan, a country presenting several unique characteristics:
-
Firstly, Jordan is less reliant on external donor funds
-
Secondly, over 75 percent of the Jordanian population is insured under one health insurance scheme or another, and close to 6% are enrolled in multiple health insurance plans
-
Thirdly, Jordan has a different structure of health care provision with three different health care systems, each providing care services for approximately one-third of the population
-
Fourthly, there is a considerable amount of high quality local manufacturing of drugs in Jordan and the pharmaceutical manufacturing sector is also exporting to other countries in the region
-
Lastly but equally important is the presence of a strong and well established regulatory and pricing authority: The Jordan Drug and Food Administration
The key objectives of this assessment will include:
-
To understand the structure of the pharmaceutical supply chain Jordan using a rigorous study framework
-
To identify bottlenecks in the pharmaceutical supply chain that limit access to medicines and strategies to alleviate those bottlenecks
-
To assist Jordan in the development of policy recommendations to improve procurement, distribution and pricing of medicines in both the public and private sectors
Participating Organizations
Zaragoza Logistics Center
